Table 1.

Short-term dynamics of lyso-Gb1 response to enzyme replacement therapy in GD patients.

Patient ID	GD1/3	Genotype	Lyso-Gb1 before [ng/mL]	Lyso-Gb1 after [ng/mL]
7	1	D438H/R87W	42	41.4
			31.2	34.9
20	1	N370S/c.1085C>T	50.6	47.9
28	1	D448G/R202X	54.3	51.2
			55	50
32	1	Unknown	45.7	39.8
35	1	N370S/L444P	33.3	24.6
NEW PATIENT ID1	1	N370S/N370S	63	49.4
NEW PATIENT ID2	1	N370S/L444P	47.6	42.7
NEW PATIENT ID3	1	N370S/ R202X	43.9	33.2
NEW PATIENT ID4	1	N370S/L444P	47.8	27.1
NEW PATIENT ID5	1	N370S/L444P	546	471
NEW PATIENT ID6	1	N370S/L444P	563	469
NEW PATIENT ID7	1	N370S/N370S	44.6	38.5
NEW PATIENT ID8	1	N370S/L444P	34.4	25.1
NEW PATIENT ID9	1	N370S/c.1085C>T	47.9	46.9
26	1	N370S/ R202X	42.4	30.6
NEW PATIENT ID10	1	N370S/c.1085C>T	37.3	34.6
NEW PATIENT ID11	3	L444P/L444P	52.3	39.6
59	3	L444P/L444P	59.7	33.7
71	3	L444P/L444P	145	148
			96.3	67.4
			71.4	65
72	3	L444P/L444P	53.9	48.5
			49.6	41.5